Progressive Care Reports 45% Year-over-Year Sales Increase
MIAMI, FL -- October 13, 2016 -- InvestorsHub NewsWire
-- Progressive Care Inc. (OTC
PINK: RXMD), through its subsidiary Pharmco LLC, a South
Florida health services organization and provider of prescription
pharmaceuticals specializing in health practice risk management,
compounded medications, the sale of anti-retroviral medications and
related medication therapy management, and the supply of
prescription medications to long term care facilities, announces
strong September 2016 sales.
PharmCo exceeded all expectations for the month of September,
filling over 19,000 prescriptions and attaining over $1.6 million
in revenue. Prescriptions filled increased 10% over the same month
last year which yielded a 45% increase in revenues. Demand for
PharmCos products and services continue to increase as new
facilities and healthcare organizations reach out to the Company
for support.
We are exceeding all of our goals month after month, stated S.
Parikh Mars, CEO. The Company continues to lead the industry in the
quality and breadth of services we provide, which has allowed us to
become one of the most sought after healthcare services companies
in South Florida.
About Progressive Care
Progressive Care, Inc. (OTC PINK: RXMD), through its subsidiary
PharmCo, LLC, is a South Florida health services organization and
provider of prescription pharmaceuticals specializing in health
practice risk management, compounded medications, the sale of
anti-retroviral medications and related medication therapy
management, and the supply of prescription medications to long term
care facilities.
Common Shares Issued and Outstanding:
As of October 13, 2016 the number of shares of common stock
issued and outstanding stood at 341,107,607 shares. This amount is net of the
number of shares owned by PharmCo, LLC of 1,718,000.
Cautionary Statement Regarding Forward Looking Statements
Statements contained herein that are not based upon current or
historical fact are forward-looking in nature and constitute
forward-looking statements within the meaning of Section 27A of the
Securities Act of 1933 and Section 21E of the Securities Exchange
Act of 1934. Such forward-looking statements reflect the Companys
expectations about its future operating results, performance and
opportunities that involve substantial risks and uncertainties.
These statements include but are not limited to statements
regarding the intended terms of the offering, closing of the
offering and use of any proceeds from the offering. When used
herein, the words anticipate, believe, estimate, upcoming, plan,
target, intend and expect and similar expressions, as they relate
to Progressive Care Inc., its subsidiaries, or its management, are
intended to identify such forward-looking statements. These
forward-looking statements are based on information currently
available to the Company and are subject to a number of risks,
uncertainties, and other factors that could cause the Company's
actual results, performance, prospects, and opportunities to differ
materially from those expressed in, or implied by, these
forward-looking statements.
Contact
Armen Karapetyan
Senior Advisor Business Development
armen@progressivecareus.com